The global market for Medical Infection Control was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Medical Infection Control, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Medical Infection Control by region & country, by Type, and by Application.
The Medical Infection Control market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Infection Control.
麻豆原创 Segmentation
By Company
Getinge Group
STERIS
Clorox Professional
Xenex
Tru-D SmartUVC
Seal Shield
American Ultraviolet
UVC Cleaning Systems
Infection Prevention Technologies
AquiSense Technologies
Lumalier Corp
American Air & Waters
Fortive
Belimed Group
Cantel Medical
Cretex Companies
E-Beam Services
Medistri
BGS
Sterigenics
Cosmed Group
Noxilizer
Johnson & Johnson
Stryker
Segment by Type:
Disinfectors
Flushers
Washers
Segment by Application
Elder Care
Hospitals and Clinics
Pharmaceutical and Life Sciences Industry
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Medical Infection Control manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Medical Infection Control in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Medical Infection Control in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Medical Infection Control Product Introduction
1.2 Global Medical Infection Control 麻豆原创 Size Forecast
1.3 Medical Infection Control 麻豆原创 Trends & Drivers
1.3.1 Medical Infection Control Industry Trends
1.3.2 Medical Infection Control 麻豆原创 Drivers & Opportunity
1.3.3 Medical Infection Control 麻豆原创 Challenges
1.3.4 Medical Infection Control 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Medical Infection Control Players Revenue Ranking (2023)
2.2 Global Medical Infection Control Revenue by Company (2019-2024)
2.3 Key Companies Medical Infection Control Manufacturing Base Distribution and Headquarters
2.4 Key Companies Medical Infection Control Product Offered
2.5 Key Companies Time to Begin Mass Production of Medical Infection Control
2.6 Medical Infection Control 麻豆原创 Competitive Analysis
2.6.1 Medical Infection Control 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Medical Infection Control Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Infection Control as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Disinfectors
3.1.2 Flushers
3.1.3 Washers
3.2 Global Medical Infection Control Sales Value by Type
3.2.1 Global Medical Infection Control Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Medical Infection Control Sales Value, by Type (2019-2030)
3.2.3 Global Medical Infection Control Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Elder Care
4.1.2 Hospitals and Clinics
4.1.3 Pharmaceutical and Life Sciences Industry
4.2 Global Medical Infection Control Sales Value by Application
4.2.1 Global Medical Infection Control Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Medical Infection Control Sales Value, by Application (2019-2030)
4.2.3 Global Medical Infection Control Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Medical Infection Control Sales Value by Region
5.1.1 Global Medical Infection Control Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Medical Infection Control Sales Value by Region (2019-2024)
5.1.3 Global Medical Infection Control Sales Value by Region (2025-2030)
5.1.4 Global Medical Infection Control Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Medical Infection Control Sales Value, 2019-2030
5.2.2 North America Medical Infection Control Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Medical Infection Control Sales Value, 2019-2030
5.3.2 Europe Medical Infection Control Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Medical Infection Control Sales Value, 2019-2030
5.4.2 Asia Pacific Medical Infection Control Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Medical Infection Control Sales Value, 2019-2030
5.5.2 South America Medical Infection Control Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Medical Infection Control Sales Value, 2019-2030
5.6.2 Middle East & Africa Medical Infection Control Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Medical Infection Control Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Medical Infection Control Sales Value
6.3 United States
6.3.1 United States Medical Infection Control Sales Value, 2019-2030
6.3.2 United States Medical Infection Control Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Medical Infection Control Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Medical Infection Control Sales Value, 2019-2030
6.4.2 Europe Medical Infection Control Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Medical Infection Control Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Medical Infection Control Sales Value, 2019-2030
6.5.2 China Medical Infection Control Sales Value by Type (%), 2023 VS 2030
6.5.3 China Medical Infection Control Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Medical Infection Control Sales Value, 2019-2030
6.6.2 Japan Medical Infection Control Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Medical Infection Control Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Medical Infection Control Sales Value, 2019-2030
6.7.2 South Korea Medical Infection Control Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Medical Infection Control Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Medical Infection Control Sales Value, 2019-2030
6.8.2 Southeast Asia Medical Infection Control Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Medical Infection Control Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Medical Infection Control Sales Value, 2019-2030
6.9.2 India Medical Infection Control Sales Value by Type (%), 2023 VS 2030
6.9.3 India Medical Infection Control Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Getinge Group
7.1.1 Getinge Group Profile
7.1.2 Getinge Group Main Business
7.1.3 Getinge Group Medical Infection Control Products, Services and Solutions
7.1.4 Getinge Group Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.1.5 Getinge Group Recent Developments
7.2 STERIS
7.2.1 STERIS Profile
7.2.2 STERIS Main Business
7.2.3 STERIS Medical Infection Control Products, Services and Solutions
7.2.4 STERIS Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.2.5 STERIS Recent Developments
7.3 Clorox Professional
7.3.1 Clorox Professional Profile
7.3.2 Clorox Professional Main Business
7.3.3 Clorox Professional Medical Infection Control Products, Services and Solutions
7.3.4 Clorox Professional Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.3.5 Xenex Recent Developments
7.4 Xenex
7.4.1 Xenex Profile
7.4.2 Xenex Main Business
7.4.3 Xenex Medical Infection Control Products, Services and Solutions
7.4.4 Xenex Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.4.5 Xenex Recent Developments
7.5 Tru-D SmartUVC
7.5.1 Tru-D SmartUVC Profile
7.5.2 Tru-D SmartUVC Main Business
7.5.3 Tru-D SmartUVC Medical Infection Control Products, Services and Solutions
7.5.4 Tru-D SmartUVC Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.5.5 Tru-D SmartUVC Recent Developments
7.6 Seal Shield
7.6.1 Seal Shield Profile
7.6.2 Seal Shield Main Business
7.6.3 Seal Shield Medical Infection Control Products, Services and Solutions
7.6.4 Seal Shield Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.6.5 Seal Shield Recent Developments
7.7 American Ultraviolet
7.7.1 American Ultraviolet Profile
7.7.2 American Ultraviolet Main Business
7.7.3 American Ultraviolet Medical Infection Control Products, Services and Solutions
7.7.4 American Ultraviolet Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.7.5 American Ultraviolet Recent Developments
7.8 UVC Cleaning Systems
7.8.1 UVC Cleaning Systems Profile
7.8.2 UVC Cleaning Systems Main Business
7.8.3 UVC Cleaning Systems Medical Infection Control Products, Services and Solutions
7.8.4 UVC Cleaning Systems Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.8.5 UVC Cleaning Systems Recent Developments
7.9 Infection Prevention Technologies
7.9.1 Infection Prevention Technologies Profile
7.9.2 Infection Prevention Technologies Main Business
7.9.3 Infection Prevention Technologies Medical Infection Control Products, Services and Solutions
7.9.4 Infection Prevention Technologies Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.9.5 Infection Prevention Technologies Recent Developments
7.10 AquiSense Technologies
7.10.1 AquiSense Technologies Profile
7.10.2 AquiSense Technologies Main Business
7.10.3 AquiSense Technologies Medical Infection Control Products, Services and Solutions
7.10.4 AquiSense Technologies Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.10.5 AquiSense Technologies Recent Developments
7.11 Lumalier Corp
7.11.1 Lumalier Corp Profile
7.11.2 Lumalier Corp Main Business
7.11.3 Lumalier Corp Medical Infection Control Products, Services and Solutions
7.11.4 Lumalier Corp Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.11.5 Lumalier Corp Recent Developments
7.12 American Air & Waters
7.12.1 American Air & Waters Profile
7.12.2 American Air & Waters Main Business
7.12.3 American Air & Waters Medical Infection Control Products, Services and Solutions
7.12.4 American Air & Waters Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.12.5 American Air & Waters Recent Developments
7.13 Fortive
7.13.1 Fortive Profile
7.13.2 Fortive Main Business
7.13.3 Fortive Medical Infection Control Products, Services and Solutions
7.13.4 Fortive Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.13.5 Fortive Recent Developments
7.14 Belimed Group
7.14.1 Belimed Group Profile
7.14.2 Belimed Group Main Business
7.14.3 Belimed Group Medical Infection Control Products, Services and Solutions
7.14.4 Belimed Group Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.14.5 Belimed Group Recent Developments
7.15 Cantel Medical
7.15.1 Cantel Medical Profile
7.15.2 Cantel Medical Main Business
7.15.3 Cantel Medical Medical Infection Control Products, Services and Solutions
7.15.4 Cantel Medical Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.15.5 Cantel Medical Recent Developments
7.16 Cretex Companies
7.16.1 Cretex Companies Profile
7.16.2 Cretex Companies Main Business
7.16.3 Cretex Companies Medical Infection Control Products, Services and Solutions
7.16.4 Cretex Companies Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.16.5 Cretex Companies Recent Developments
7.17 E-Beam Services
7.17.1 E-Beam Services Profile
7.17.2 E-Beam Services Main Business
7.17.3 E-Beam Services Medical Infection Control Products, Services and Solutions
7.17.4 E-Beam Services Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.17.5 E-Beam Services Recent Developments
7.18 Medistri
7.18.1 Medistri Profile
7.18.2 Medistri Main Business
7.18.3 Medistri Medical Infection Control Products, Services and Solutions
7.18.4 Medistri Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.18.5 Medistri Recent Developments
7.19 BGS
7.19.1 BGS Profile
7.19.2 BGS Main Business
7.19.3 BGS Medical Infection Control Products, Services and Solutions
7.19.4 BGS Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.19.5 BGS Recent Developments
7.20 Sterigenics
7.20.1 Sterigenics Profile
7.20.2 Sterigenics Main Business
7.20.3 Sterigenics Medical Infection Control Products, Services and Solutions
7.20.4 Sterigenics Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.20.5 Sterigenics Recent Developments
7.21 Cosmed Group
7.21.1 Cosmed Group Profile
7.21.2 Cosmed Group Main Business
7.21.3 Cosmed Group Medical Infection Control Products, Services and Solutions
7.21.4 Cosmed Group Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.21.5 Cosmed Group Recent Developments
7.22 Noxilizer
7.22.1 Noxilizer Profile
7.22.2 Noxilizer Main Business
7.22.3 Noxilizer Medical Infection Control Products, Services and Solutions
7.22.4 Noxilizer Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.22.5 Noxilizer Recent Developments
7.23 Johnson & Johnson
7.23.1 Johnson & Johnson Profile
7.23.2 Johnson & Johnson Main Business
7.23.3 Johnson & Johnson Medical Infection Control Products, Services and Solutions
7.23.4 Johnson & Johnson Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.23.5 Johnson & Johnson Recent Developments
7.24 Stryker
7.24.1 Stryker Profile
7.24.2 Stryker Main Business
7.24.3 Stryker Medical Infection Control Products, Services and Solutions
7.24.4 Stryker Medical Infection Control Revenue (US$ Million) & (2019-2024)
7.24.5 Stryker Recent Developments
8 Industry Chain Analysis
8.1 Medical Infection Control Industrial Chain
8.2 Medical Infection Control Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Medical Infection Control Sales Model
8.5.2 Sales Channel
8.5.3 Medical Infection Control Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Getinge Group
STERIS
Clorox Professional
Xenex
Tru-D SmartUVC
Seal Shield
American Ultraviolet
UVC Cleaning Systems
Infection Prevention Technologies
AquiSense Technologies
Lumalier Corp
American Air & Waters
Fortive
Belimed Group
Cantel Medical
Cretex Companies
E-Beam Services
Medistri
BGS
Sterigenics
Cosmed Group
Noxilizer
Johnson & Johnson
Stryker
听
听
*If Applicable.
